HeartCore Announces 1-for-20 Reverse Stock Split
Rhea-AI Summary
HeartCore (NASDAQ: HTCR) approved a 1-for-20 reverse stock split effective April 2, 2026 at 4:00 p.m. ET, with trading expected on a split-adjusted basis under a new CUSIP (42240Q203) on Nasdaq beginning April 6, 2026.
The Reverse Split is intended to increase the per-share price to regain compliance with Nasdaq's $1.00 minimum bid requirement. Outstanding options, restricted stock units, and plan reserves will be proportionally adjusted; fractional shares will be rounded up. Transfer agent Transhare Corporation will handle certificate exchanges.
Positive
- Reverse split ratio set at 1-for-20 effective April 2, 2026
- Action intended to regain Nasdaq $1.00 minimum bid compliance
- Outstanding options and RSUs will be proportionally adjusted
Negative
- Issued shares will be reduced by a factor of 20, lowering public float
- Reverse split reflects prior non-compliance with Nasdaq’s $1.00 minimum bid
News Market Reaction – HTCR
On the day this news was published, HTCR declined 26.13%, reflecting a significant negative market reaction. Argus tracked a trough of -35.6% from its starting point during tracking. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $5.70M at that time. Trading volume was exceptionally heavy at 6.2x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
HTCR traded at $0.2243 (+3.94%) while 4 peers flagged by momentum screens also moved up (median change about 7.5%), suggesting broader sector strength alongside the reverse split news.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 24 | Share repurchase plan | Positive | +14.0% | Authorized $2.0M buyback after noting net assets above market cap. |
| Feb 11 | Preliminary earnings | Positive | -1.7% | Preliminary FY2025 results with $8.5M–$9.5M revenue and return to profit. |
| Nov 18 | Q3 earnings | Negative | -18.7% | Q3 revenue drop to $3.0M vs $16.2M and weaker YTD metrics. |
| Nov 10 | Nasdaq extension | Negative | -14.2% | Received 180-day extension to regain $1.00 minimum bid compliance. |
| Oct 31 | Business divestiture | Positive | +7.2% | Sold software subsidiary for ~¥1.8B and declared $0.13 per-share distribution. |
HTCR’s price usually moved in the same direction as news tone, with one divergence on preliminary FY2025 results.
Over the last six months, HTCR has restructured around its Go IPO consulting business, divesting HeartCore Japan for about ¥1.8 billion and paying a $0.13 per share distribution. It later received a 180-day Nasdaq bid-price extension to May 1, 2026. Earnings updates showed profitability despite lower revenue, and a $2.0 million repurchase authorization boosted shares. Today’s reverse split fits into efforts to address the persistent sub-$1.00 share price and listing pressure.
Market Pulse Summary
The stock dropped -26.1% in the session following this news. A negative reaction despite the reverse split would fit a pattern where listing compliance steps, like prior Nasdaq bid-price extensions, coincided with pressure on HTCR’s shares. The low pre-split price of $0.2243 and history of sharp post-news swings, including double-digit percentage drops around earnings updates, could have amplified downside. Reverse splits alone do not change fundamentals, so sentiment around the broader restructuring remained important.
Key Terms
reverse stock split financial
cusip financial
par value financial
equity incentive plans financial
book-entry technical
transfer agent financial
AI-generated analysis. Not financial advice.
NEW YORK and TOKYO, April 01, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (NASDAQ: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, today announced that its Board of Directors approved a 1-for-20 reverse stock split of its issued and outstanding common stock (the “Reverse Split”). As previously announced, on June 30, 2025, HeartCore stockholders approved the Reverse Split and granted the Board of Directors the authority to determine the exact split ratio (within the range approved by stockholders) and when to proceed with the Reverse Split.
The Reverse Split will become effective on April 2, 2026 at 4:00 p.m. Eastern Time (“Effective Time”) and the Company's common stock is expected to begin trading under a new CUSIP number, 42240Q 203, on the Nasdaq Capital Market (“Nasdaq”) on April 6, 2026, on a Reverse Split-adjusted basis. The Reverse Split is intended to increase the price per share of the Company’s common stock to enable the Company to regain compliance with the
As of the Effective Time, issued and outstanding shares of the Company’s common stock will automatically be reclassified such that each 20 shares of pre-Reverse Split common stock will become one share of common stock, with any fractional shares of common stock resulting being rounded up to the nearest whole share of common stock. The authorized number of shares, and par value per share, of the Company’s common stock will not be affected by the Reverse Split. Proportional adjustments will be made to the number of shares of common stock issuable upon the exercise of the Company's outstanding options and restricted stock units, and the number of shares authorized and reserved for issuance pursuant to the Company's equity incentive plans.
Stockholders holding their shares electronically in book-entry form are not required to take any action to receive post-Reverse Split shares. Stockholders owning shares through a bank, broker, or other nominee will have their positions automatically adjusted to reflect the Reverse Split, subject to brokers’ particular processes, and will not be required to take any action in connection with the Reverse Split. For those stockholders holding physical stock certificates, the Company’s transfer agent, Transhare Corporation, will send instructions for exchanging those certificates for shares held electronically in book-entry form or for new certificates, in either case representing the post-Reverse Split number of shares.
About HeartCore Enterprises, Inc.
HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.
Forward-Looking Statements
All statements other than statements of historical facts included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding the potential transaction, strategic initiatives, regulatory processes, and future business plans.
In some cases, forward-looking statements can be identified by words such as “believe,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these statements.
These risks and uncertainties are discussed in the Company’s filings with the U.S. Securities and Exchange Commission. Investors are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
HeartCore Investor Relations Contact:
Gateway Group, Inc.
Matt Glover and John Yi
HTCR@gateway-grp.com
(949) 574-3860